ATE140728T1 - Lipopeptid deacylase - Google Patents

Lipopeptid deacylase

Info

Publication number: ATE140728T1
Authority: AT; Austria
Prior art keywords: enzyme; deacylase; lipid; cyclicpeptide; aculeacin
Prior art date: 1990-06-07

Application number

AT91304976T

Other languages

English (en)

Inventor

Adam Joseph Kreusman

Wu-Kuang Yeh

Original Assignee

Lilly Co Eli

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-06-07

Filing date

1991-06-03

Publication date

1996-08-15

1991-06-03 Application filed by Lilly Co Eli filed Critical Lilly Co Eli

1996-08-15 Application granted granted Critical

1996-08-15 Publication of ATE140728T1 publication Critical patent/ATE140728T1/de

Links

108010028921 Lipopeptides Proteins 0.000 title 1
102000004190 Enzymes Human genes 0.000 abstract 4
108090000790 Enzymes Proteins 0.000 abstract 4
241000187840 Actinoplanes utahensis Species 0.000 abstract 1
108010069514 Cyclic Peptides Proteins 0.000 abstract 1
102000001189 Cyclic Peptides Human genes 0.000 abstract 1
108010049047 Echinocandins Proteins 0.000 abstract 1
238000005277 cation exchange chromatography Methods 0.000 abstract 1
239000002738 chelating agent Substances 0.000 abstract 1
230000020176 deacylation Effects 0.000 abstract 1
238000005947 deacylation reaction Methods 0.000 abstract 1
108010062092 echinocandin B Proteins 0.000 abstract 1
FAUOJMHVEYMQQG-HVYQDZECSA-N echinocandin B Chemical compound C1([C@H](O)[C@@H](O)[C@H]2C(=O)N[C@H](C(=O)N3C[C@H](C)[C@H](O)[C@H]3C(=O)N[C@H](O)[C@H](O)C[C@@H](C(N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)N2)[C@@H](C)O)=O)NC(=O)CCCCCCC\C=C/C\C=C/CCCCC)[C@@H](C)O)=CC=C(O)C=C1 FAUOJMHVEYMQQG-HVYQDZECSA-N 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
238000002523 gelfiltration Methods 0.000 abstract 1
239000000833 heterodimer Substances 0.000 abstract 1
238000004191 hydrophobic interaction chromatography Methods 0.000 abstract 1
150000002632 lipids Chemical class 0.000 abstract 1
239000002207 metabolite Substances 0.000 abstract 1
239000002184 metal Substances 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
239000003774 sulfhydryl reagent Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
- C12N9/80—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/50—Cyclic peptides containing at least one abnormal peptide link
- C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
- C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/814—Enzyme separation or purification
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/814—Enzyme separation or purification
- Y10S435/815—Enzyme separation or purification by sorption

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biophysics (AREA)
General Engineering & Computer Science (AREA)
Microbiology (AREA)
Biotechnology (AREA)
Biomedical Technology (AREA)
Enzymes And Modification Thereof (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Macromonomer-Based Addition Polymer (AREA)
Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Prostheses (AREA)
External Artificial Organs (AREA)
Orthopedics, Nursing, And Contraception (AREA)
Peptides Or Proteins (AREA)

AT91304976T 1990-06-07 1991-06-03 Lipopeptid deacylase ATE140728T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US53439490A	1990-06-07	1990-06-07

Publications (1)

Publication Number	Publication Date
ATE140728T1 true ATE140728T1 (de)	1996-08-15

Family

ID=24129856

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT91304976T ATE140728T1 (de)	1990-06-07	1991-06-03	Lipopeptid deacylase

Country Status (14)

Country	Link
US (1)	US5573936A (de)
EP (1)	EP0460882B1 (de)
JP (1)	JP2994486B2 (de)
KR (1)	KR0169994B1 (de)
AT (1)	ATE140728T1 (de)
CA (1)	CA2043762C (de)
DE (1)	DE69121018T2 (de)
DK (1)	DK0460882T3 (de)
ES (1)	ES2089133T3 (de)
GR (1)	GR3021292T3 (de)
HU (1)	HU215232B (de)
IE (1)	IE75885B1 (de)
IL (1)	IL98349A (de)
TW (1)	TW197471B (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6743777B1 (en)	1992-03-19	2004-06-01	Eli Lilly And Company	Cyclic peptide antifungal agents and process for preparation thereof
ATE544851T1 (de) *	1996-03-08	2012-02-15	Astellas Pharma Inc	Verfahren zur deacylierung von zyklischen lipopeptiden
WO1997047738A1 (en) *	1996-06-13	1997-12-18	Fujisawa Pharmaceutical Co., Ltd.	Cyclic lipopeptide acylase
US6153410A (en) *	1997-03-25	2000-11-28	California Institute Of Technology	Recombination of polynucleotide sequences using random or defined primers
US6361988B1 (en)	1997-03-25	2002-03-26	California Institute Of Technology	ECB deacylase mutants
US5936074A (en) *	1997-04-17	1999-08-10	Eli Lilly And Company	Teicoplanin deacylation process and product
US6323176B1 (en)	1998-02-25	2001-11-27	Eli Lilly And Company	Cyclic peptide antifungal agents
BR9916101A (pt)	1998-12-09	2002-06-04	Lilly Co Eli	Purificação de compostos de ciclopeptìdeos equinocandinos
CA2362016A1 (en)	1999-03-03	2000-09-08	Kenneth Philip Moder	Echinocandin/carbohydrate complexes
CN1351610A (zh)	1999-03-03	2002-05-29	伊莱利利公司	晶体棘白菌素铵盐的生成和阴离子交换
RU2250763C2 (ru)	1999-03-03	2005-04-27	Эли Лилли Энд Компани	Фармацевтические препараты эхинокандина, содержащие мицелообразующие поверхностно-активные вещества
HK1040369A1 (zh)	1999-03-03	2002-06-07	Eli Lilly And Company	制备药物口服ecb配方和组合物的方法
EA200200162A1 (ru) *	1999-07-15	2002-06-27	Эли Лилли Энд Компани	Способ деацилирования липодепсипептидов
MXPA02006030A (es) *	1999-12-15	2004-08-23	Cubist Pharm Inc	Lipopeptidos como agentes antibacterianos.
JP4990456B2 (ja)	1999-12-15	2012-08-01	キュービストファーマシューティカルズ，インコーポレイテッド	抗菌剤としてのダプトマイシンアナログ
KR20020063230A (ko) *	1999-12-15	2002-08-01	큐비스트 파마슈티컬즈 인코포레이티드	항균제로서의 신규한 리포펩티드
US6696412B1 (en) *	2000-01-20	2004-02-24	Cubist Pharmaceuticals, Inc.	High purity lipopeptides, Lipopeptide micelles and processes for preparing same
US20060014674A1 (en)	2000-12-18	2006-01-19	Dennis Keith	Methods for preparing purified lipopeptides
JP2005531486A (ja) *	2001-08-06	2005-10-20	キュービストファーマシューティカルズ，インコーポレイテッド	新規のデプシペプチドおよびこれを調製するためのプロセス
US6991800B2 (en)	2002-06-13	2006-01-31	Vicuron Pharmaceuticals Inc.	Antifungal parenteral products
DE102004060750A1 (de) *	2004-12-15	2006-07-13	Sanofi-Aventis Deutschland Gmbh	Verfahren zur Deacylierung von Lipopeptiden
PL2379580T3 (pl) *	2008-12-22	2014-05-30	Merck Sharp & Dohme	Nowe środki przeciwbakteryjne do leczenia zakażeń wywołanych bakteriami Gram-dodatnimi
US9394340B2 (en) *	2009-03-24	2016-07-19	Cadila Healthcare Limited	Purification process for lipopeptides
IN2015DN01633A (de)	2012-09-24	2015-07-03	Dsm Sinochem Pharm Nl Bv
KR101425108B1 (ko) *	2012-09-25	2014-07-31	동국제약 주식회사	탈아실화된 환상 리포펩티드의 제조방법
CN108410929B (zh) *	2018-05-30	2024-01-26	博瑞生物医药（苏州）股份有限公司	阿尼芬净前体的制备方法
CN109593809A (zh) *	2018-12-07	2019-04-09	成都雅途生物技术有限公司	一种固定化微生物酶转化棘白菌素b的方法
CN113215185B (zh) *	2021-04-22	2022-04-29	浙江工业大学	一种用于重组表达棘白菌素b脱酰基酶的重组基因序列

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1159450A (en) *	1979-12-13	1983-12-27	Manuel Debono	Process for the preparation of derivatives of cyclic peptide nuclei

1991
- 1991-06-03 AT AT91304976T patent/ATE140728T1/de not_active IP Right Cessation
- 1991-06-03 DK DK91304976.3T patent/DK0460882T3/da active
- 1991-06-03 CA CA002043762A patent/CA2043762C/en not_active Expired - Fee Related
- 1991-06-03 EP EP91304976A patent/EP0460882B1/de not_active Expired - Lifetime
- 1991-06-03 ES ES91304976T patent/ES2089133T3/es not_active Expired - Lifetime
- 1991-06-03 DE DE69121018T patent/DE69121018T2/de not_active Expired - Fee Related
- 1991-06-03 IL IL9834991A patent/IL98349A/en not_active IP Right Cessation
- 1991-06-04 JP JP3132622A patent/JP2994486B2/ja not_active Expired - Fee Related
- 1991-06-05 KR KR1019910009280A patent/KR0169994B1/ko not_active Expired - Fee Related
- 1991-06-06 IE IE193991A patent/IE75885B1/en not_active IP Right Cessation
- 1991-06-06 HU HU911897A patent/HU215232B/hu not_active IP Right Cessation
- 1991-06-06 TW TW080104442A patent/TW197471B/zh active
1995
- 1995-05-18 US US08/444,126 patent/US5573936A/en not_active Expired - Fee Related
1996
- 1996-10-09 GR GR960402663T patent/GR3021292T3/el unknown

Also Published As

Publication number	Publication date
DE69121018D1 (de)	1996-08-29
KR0169994B1 (ko)	1999-02-01
IL98349A (en)	1995-05-26
CA2043762A1 (en)	1991-12-08
IE75885B1 (en)	1997-09-24
TW197471B (de)	1993-01-01
JP2994486B2 (ja)	1999-12-27
DK0460882T3 (da)	1996-08-26
GR3021292T3 (en)	1997-01-31
ES2089133T3 (es)	1996-10-01
IL98349A0 (en)	1992-07-15
US5573936A (en)	1996-11-12
EP0460882A3 (en)	1992-04-22
DE69121018T2 (de)	1996-12-19
IE911939A1 (en)	1991-12-18
HUT61587A (en)	1993-01-28
HU215232B (hu)	1998-11-30
EP0460882A2 (de)	1991-12-11
KR920000919A (ko)	1992-01-29
CA2043762C (en)	2001-05-29
EP0460882B1 (de)	1996-07-24
HU911897D0 (en)	1991-12-30
JPH04228072A (ja)	1992-08-18

Legal Events

Date	Code	Title	Description
1997-02-15	UEP	Publication of translation of european patent specification
2004-03-15	REN	Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
ATE140728T1 (de)	1996-08-15	Lipopeptid deacylase
ES2124295T3 (es)	1999-02-01	Expresion y purificacion de factor tisular soluble recombinante.
DE69332879D1 (de)	2003-05-22	Technetium-99-markierte peptide zur visualisierung vom entzuendungen
EP0746398A4 (de)	1997-10-08	Antikörperreinigung
PT1062325E (pt)	2006-05-31	Purificacao de preparacoes de virus
DK163520C (da)	1992-07-27	Substitueret androsta-1,4-dien-3,17-dioner, fremgangsmaade til fremstilling deraf, praeparater indeholdende saadanne forbindelser samt anvendelsen af disse til fremstilling af farmaceutiske praeparater
DK0464140T3 (da)	1994-09-05	Aktivt adhæsionspeptid
DK289285A (da)	1985-12-28	Thymopentin analoge
JPH02500022U (de)	1990-04-26
NO952336L (no)	1995-06-13	Insulin analoger
DE69330352D1 (de)	2001-07-19	Mittel und methoden zur verbesserung der keratinocytenadhäsion an der haut
PT1107981E (pt)	2005-05-31	Sintese de analogos peptidicos ciclicos de anel modificado
GB9311454D0 (en)	1993-07-21	Pharmaceutical compositions
ES2195409T3 (es)	2003-12-01	Purificacion de moleculas.
AU5435990A (en)	1990-11-05	Monoclonal antibodies to human glutathione s transferase pi
ITRM920809A1 (it)	1994-05-06	Interleuchina-6 mutante con attivita' biologica migliorata rispetto all'interleuchina-6 selvatica.
NO891713D0 (no)	1989-04-25	Monoklonale antistoffer til vevplasminogenaktivator (t-pa)
KR920011511A (ko)	1992-07-24	항종양 면역증강효과가 있는 단백다당체(g 009)
SANTIS	1996	Spherical cap harmonic analysis of local gravity field
DK412389D0 (da)	1989-01-19	Fremgangsmaade til udvinding af oprenset epi protein fra en fermenteringsoploesning
GLAVCHEVA	1996	On the Worth of Staiko Staikov's Collection in Historical Seismology
DK268889A (da)	1989-12-08	Cykliske d-cys6-peptidforbindelser, fremgangsmaader til fremstilling heraf samt farmaceutiske midler indeholdende disse
Lopez-Trascasa et al.	1982	Isolation and characterization of a biologically active C2 derived oligopeptide
Monahan et al.	1982	Studies of the interaction of C8 and C9 within the membrane-bound cytolytic complex of complement
Smith et al.	1982	Ultrastructural studies of the human complement components C3 and factor B and of cobra venom factor (CVF)